Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196):企業の財務・戦略的SWOT分析

◆英語タイトル:Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14802
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥39,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism and digestive system, cardiovascular system, blood system, central nervous system drugs, anti-infection, anti-tumor, vaccine and raw material and intermediates. It provides medical diagnostic products such as real time PCR detector, human papillomavirus assay kit, HBV quantitative reagent, and biofosun microorganism identification and susceptibility analysis system. The company’s research and development unit concentrates on therapeutic areas of metabolism and digestive system, blood system, cardiovascular system and central nervous system. Fosun Pharma is headquartered in Shanghai City, Shanghai, China.

Shanghai Fosun Pharmaceutical (Group) Co Ltd Key Recent Developments

Oct 29,2018: Fosun Pharma announces 2018 Q3 results, revenue increased 39.99% year on year operating cash flow increased 21.15% year on year R&D investment increased 59.13 % year on year
Aug 28,2018: Sirona Biochem Receives $500,000 USD Milestone Payment from Wanbang Biopharmaceuticals
Aug 27,2018: Fosun Pharma announces 2018 interim results focus on substantial increase in R&D investment and active future planning revenue
Mar 27,2018: Fosun pharma: Announcement of Final Results for the Year Ended 31 December 2017
Mar 26,2018: Change In Fosun Pharma’s Board Of Directors To Further Align Group Strategy

This comprehensive SWOT profile of Shanghai Fosun Pharmaceutical (Group) Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Shanghai Fosun Pharmaceutical (Group) Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Shanghai Fosun Pharmaceutical (Group) Co Ltd – Key Information
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Overview
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Key Employees
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Key Employee Biographies
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Key Operational Heads
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Major Products and Services
Shanghai Fosun Pharmaceutical (Group) Co Ltd – History
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Company Statement
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Locations And Subsidiaries
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Shanghai Fosun Pharmaceutical (Group) Co Ltd – Business Description
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Corporate Strategy
Shanghai Fosun Pharmaceutical (Group) Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Strengths
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Weaknesses
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Opportunities
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Threats
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Shanghai Fosun Pharmaceutical (Group) Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Information
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Ratios
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Share Data
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Major Products and Services
Shanghai Fosun Pharmaceutical (Group) Co Ltd, History
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Employees
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Employee Biographies
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Operational Heads
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Other Locations
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Subsidiaries
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Manufacturing facilities
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Competitors
Shanghai Fosun Pharmaceutical (Group) Co Ltd, SWOT Analysis
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Ratios based on current share price
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Annual Ratios
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Performance Chart
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Ratio Charts

★海外企業調査レポート[Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Concho Resources Inc (CXO):企業の財務・戦略的SWOT分析
    Summary Concho Resources Inc (Concho) is an oil and gas company. It acquires, develops, produces and explores oil and natural gas properties. The company owns and operates exploration assets in the Permian Basin region of Southeast New Mexico and West Texas, an onshore oil and natural gas basin in t …
  • Treeway BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Treeway BV (Treeway) is a biotechnology company that develops drugs for the treatment of amyotrophic lateral sclerosis (ALS). The company provides pipeline products such as TW001, an oral formulation of edaravone, which protects against neuronal apoptosis and oxidative stress. It offers prod …
  • Rosseti (RSTI):電力:M&Aディール及び事業提携情報
    Summary Rosseti is an electricity grid company. It operates energy networks, and transmits and distributes electricity in Russia. Rosseti operates through a portfolio of affiliated and dependent companies including interregional and regional distribution grid companies. Through joint projects and ot …
  • Cellectis SA (ALCLS):企業の財務・戦略的SWOT分析
    Summary Cellectis SA (Cellectis) is a clinical-stage biopharmaceutical company that research, develop and commercialise rational genome engineering technologies. The company pioneers gene editing company, deploying core proprietary technologies to develop off-the-shelf immunotherapies to target and …
  • WNDM Medical Inc (WNDM):製薬・医療:M&Aディール及び事業提携情報
    Summary WNDM Medical Inc (WNDM Medical), formerly Wound Management Technologies Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone blee …
  • Martifer SGPS SA (MAR):企業の財務・戦略的SWOT分析
    Martifer SGPS SA (MAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Prudential Financial Inc:戦略・SWOT・企業財務分析
    Prudential Financial Inc - Strategy, SWOT and Corporate Finance Report Summary Prudential Financial Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • The Andersons Inc (ANDE):企業の財務・戦略的SWOT分析
    The Andersons Inc (ANDE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Playtech PLC:企業のM&A・事業提携・投資動向
    Playtech PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Playtech PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • DBS Bank Ltd:企業のM&A・事業提携・投資動向
    DBS Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DBS Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Interglobe Aviation Limited:戦略・SWOT・企業財務分析
    Interglobe Aviation Limited - Strategy, SWOT and Corporate Finance Report Summary Interglobe Aviation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • NxStage Medical Inc:企業の戦略的SWOT分析
    NxStage Medical Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Bayer AG (BAYN)-医療機器分野:企業M&A・提携分析
    Summary Bayer AG (Bayer) carries out the research, development, production and commercialization of products in the areas of human and animal health care, and agriculture. It provides pharmaceuticals for cardiology, women’s healthcare, oncology, hematology, ophthalmology, infection and other indicat …
  • Neuraltus Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Neuraltus Pharmaceuticals Inc (Neuraltus) is a biopharmaceutical company that develops and commercializes therapeutics for neurodegenerative diseases. The company offers products under clinical development that include NP001 and others. It develops macrophage which is based on the recent und …
  • Cosmo Pharmaceuticals NV (COPN):企業の財務・戦略的SWOT分析
    Summary Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix technology. Its proprietary clinical development pipeline intended for the treatment of …
  • Dyo Boya Fabrikalari Sanayi ve Tic. A.S. (DYOBY):企業の財務・戦略的SWOT分析
    Dyo Boya Fabrikalari Sanayi ve Tic. A.S. (DYOBY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • China Power Clean Energy Development Co Ltd (735):電力:M&Aディール及び事業提携情報
    Summary China Power Clean Energy Development Co Ltd (CPCE) formerly China Power New Energy Development Co Ltd, is an electric utility. It develops, constructs, owns, operates, and manages clean energy power plants. The company produces electricity through natural gas, wind, hydro, and solar sources. …
  • Lookers Plc:企業のM&A・事業提携・投資動向
    Lookers Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lookers Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Strategic Metals Ltd (SMD):企業の財務・戦略的SWOT分析
    Summary Strategic Metals Ltd (Strategic Metals) is a mining and mineral exploration company that acquires, explores, produces, and develops gold properties across Canada. Its portfolio covers a broad suite of metals, including gold, silver, lead, zinc, copper, tin, tungsten, vanadium and lithium. It …
  • Concur Technologies Inc:企業の戦略的SWOT分析
    Concur Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆